查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1659413

全球分子生物学酵素、套件和试剂市场

Molecular Biology Enzymes and Kits & Reagents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 89 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球分子生物学酵素、套件和试剂市场规模将达到 705 亿美元

2024 年全球分子生物学酶、套件和试剂市场规模估计为 324 亿美元，预计到 2030 年将达到 705 亿美元，2024-2030 年分析期内的复合年增长率为 13.9%。分子生物学套件和试剂是报告分析的细分市场之一，预计复合年增长率为 14.6%，到分析期结束时将达到 648 亿美元。在分析期内，分子生物学酶部分预计将以 7.0% 的复合年增长率增长。

美国市场规模估计为 90 亿美元，中国市场预估年复合成长率为 13.2%

预计2024年美国分子生物学酵素、套件和试剂市场规模将达 90 亿美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 108 亿美元，2024 年至 2030 年的复合年增长率为 13.2%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 12.0% 和 11.5%。在欧洲，德国的复合年增长率预计约为 9.5%。

全球分子生物学酶、套件和试剂市场 - 主要趋势和驱动因素摘要

分子生物学酵素、套件和试剂如何彻底改变研究？

分子生物学酵素、套件和试剂是各种研究应用中使用的必不可少的工具，包括 DNA序列测定、聚合酵素链锁反应(PCR)、基因克隆和蛋白质分析。这些产品在生命科学、生物技术和药物研究中发挥重要作用，使科学家能够研究遗传物质的结构、功能和相互作用。分子生物学酶，例如 DNA聚合酵素、限制性酶和连接酶，有助于操作和分析核酸，对于了解疾病、开发新治疗方法和推进基因工程至关重要。由于基因组学、蛋白质组学和个人化医疗研究活动的增加，分子生物学酶、套件和试剂的市场正在扩大。人们对遗传疾病的了解和开发标靶治疗的关注度不断提高，推动了对先进分子生物学工具的需求。製药公司和研究机构正在大力投资分子生物学研究，以加速药物发现并改善诊断技术，进一步推动市场成长。

哪些趋势推动了分子生物学酵素、套件和试剂市场的发展？

影响分子生物学酶、套件和试剂市场的主要趋势包括次世代定序仪(NGS) 的兴起、生物技术和生命科学研究的成长以及对个人化医疗的日益关注。 NGS技术透过实现DNA序列的高通量分析彻底改变了基因组研究，推动了对分子生物学酶和试剂的需求。 NGS 平台和技术的快速进步为公司开发针对定序应用的专用酵素和套件创造了机会。人们越来越重视个人化医疗，即根据个人基因组成客製化治疗方案，这也推动了对分子生物学工具的需求。研发部门正在使用这些工具来研究基因突变并开发精准治疗方法。此外，生物技术产业的扩张导致研发资金的增加，从而增加了对高品质分子生物学产品的需求，这也促进了市场的发展。

市场区隔将如何影响分子生物学酵素、套件和试剂？

产品类型包括酵素、套件和试剂，其中酵素占最大份额，因为其广泛应用于各种分子生物学技术。这些产品具有广泛的应用范围，包括研究、诊断和治疗开发，主要使用者是实验室和学术机构。最终用户部门包括学术和研究机构、医院和诊断中心以及製药和生物技术公司。由于对药物研发的投资不断增加，製药和生技产业正在经历显着的成长。从地区来看，北美凭藉先进的研究基础设施和大量生命科学资金占据市场主导地位。同时，由于研究活动的增加和政府对生物技术发展的支持，亚太地区正在经历快速成长。

哪些因素推动了分子生物学酵素、套件和试剂市场的成长？

分子生物学酶、套件和试剂市场的成长受到多种因素的推动，包括对基因研究的需求不断增加、分子生物学技术的进步以及对个人化医疗的日益关注。基因组学和蛋白​​质组学研究的扩展正在推动对分子生物学工具的需求。 NGS 和其他分子技术的发展为开发专门产品创造了机会。此外，精准医疗的成长趋势正在推动分子生物学酶、套件和试剂在标靶治疗和诊断方面的发展。

部分

产品（套件和试剂、酵素）；应用（PCR、定序、克隆、表观遗传学、其他应用）；最终用途（学术和研究、製药和生物技术、医院和诊断、其他最终用途）

受访公司范例（值得关注的33家公司）

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzymatics
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Merck KGaA
  • New England Biolabs
  • Promega Corporation
  • QIAGEN
  • Sigma-Aldrich Co. LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP22322

Global Molecular Biology Enzymes and Kits & Reagents Market to Reach US$70.5 Billion by 2030

The global market for Molecular Biology Enzymes and Kits & Reagents estimated at US$32.4 Billion in the year 2024, is expected to reach US$70.5 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Molecular Biology Kits & Reagents, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$64.8 Billion by the end of the analysis period. Growth in the Molecular Biology Enzymes segment is estimated at 7.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.0 Billion While China is Forecast to Grow at 13.2% CAGR

The Molecular Biology Enzymes and Kits & Reagents market in the U.S. is estimated at US$9.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$10.8 Billion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Molecular Biology Enzymes and Kits & Reagents Market - Key Trends and Drivers Summarized

How Are Molecular Biology Enzymes, Kits & Reagents Revolutionizing Research?

Molecular biology enzymes, kits, and reagents are essential tools used in various research applications, including DNA sequencing, polymerase chain reactions (PCR), gene cloning, and protein analysis. These products play a critical role in life sciences, biotechnology, and pharmaceutical research, enabling scientists to study the structure, function, and interactions of genetic material. Molecular biology enzymes, such as DNA polymerases, restriction enzymes, and ligases, facilitate the manipulation and analysis of nucleic acids, which is crucial for understanding diseases, developing new treatments, and advancing genetic engineering. The market for molecular biology enzymes, kits, and reagents is expanding due to increasing research activities in genomics, proteomics, and personalized medicine. With the growing focus on understanding genetic disorders and developing targeted therapies, there is a rising demand for advanced molecular biology tools. Pharmaceutical companies and research institutions are investing heavily in molecular biology research to accelerate drug discovery and improve diagnostic techniques, further fueling the market's growth.

What Trends Are Driving the Molecular Biology Enzymes, Kits & Reagents Market?

Key trends influencing the molecular biology enzymes, kits, and reagents market include the rise of next-generation sequencing (NGS), the growth of biotechnology and life sciences research, and the increasing focus on personalized medicine. NGS technologies have revolutionized genomics research by enabling high-throughput analysis of DNA sequences, driving the demand for molecular biology enzymes and reagents. The rapid advancements in NGS platforms and techniques are creating opportunities for companies to develop specialized enzymes and kits tailored for sequencing applications. The growing emphasis on personalized medicine, which involves tailoring medical treatments based on an individual's genetic makeup, is also boosting the demand for molecular biology tools. Researchers are using these tools to study genetic variations and develop precision therapies. Additionally, the expansion of the biotechnology industry, with increased funding for research and development, is further contributing to market growth by driving demand for high-quality molecular biology products.

How Do Market Segments Impact Molecular Biology Enzymes, Kits & Reagents?

Product categories include enzymes, kits, and reagents, with enzymes accounting for the largest share due to their extensive use in various molecular biology techniques. Applications of these products span across research, diagnostics, and therapeutic development, with research laboratories and academic institutions being the primary users. The end-user segment includes academic and research institutes, hospitals and diagnostic centers, and pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology segment is witnessing significant growth due to increasing investments in drug discovery and development. Geographically, North America dominates the market due to advanced research infrastructure and substantial funding for life sciences. Meanwhile, the Asia-Pacific region is experiencing rapid growth, driven by increasing research activities and government support for biotechnology development.

What Factors Are Driving the Growth in the Molecular Biology Enzymes, Kits & Reagents Market?

The growth in the molecular biology enzymes, kits, and reagents market is driven by several factors, including the rising demand for genetic research, advancements in molecular biology techniques, and the increasing focus on personalized medicine. The expansion of genomics and proteomics research is boosting the demand for molecular biology tools. Advancements in NGS and other molecular techniques are creating opportunities for the development of specialized products. Furthermore, the growing trend of precision medicine is encouraging the use of molecular biology enzymes, kits, and reagents for the development of targeted therapies and diagnostics.

SCOPE OF STUDY:

The report analyzes the Molecular Biology Enzymes and Kits & Reagents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits & Reagents, Enzymes); Application (PCR, Sequencing, Cloning, Epigenetics, Other Applications); End-Use (Academic & Research, Pharma & Biotech, Hospital & Diagnostics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 33 Featured) -

  • Affymetrix, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Enzymatics
  • F. Hoffmann-La Roche Ltd.
  • Illumina, Inc.
  • LGC Limited
  • Merck KGaA
  • New England Biolabs
  • Promega Corporation
  • QIAGEN
  • Sigma-Aldrich Co. LLC
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Molecular Biology Enzymes and Kits & Reagents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Genomics and Proteomics Research Spurs Growth in Molecular Biology Enzymes and Kits & Reagents Market
    • Technological Advancements in High-Fidelity Enzymes and PCR Kits Strengthen Business Case for Adoption
    • Growing Focus on Personalized Medicine and Diagnostic Applications Expands Addressable Market
    • Expansion of Molecular Biology Enzymes and Kits in Pharmaceutical and Biotechnology Industries Fuels Market Growth
    • Increasing Adoption of NGS (Next-Generation Sequencing) and CRISPR Technologies Expands Market Opportunities
    • Technological Innovations in Recombinant Enzymes and High-Throughput Kits Propel Market Expansion
    • Rising Focus on Enhancing Accuracy and Reproducibility in Molecular Experiments Drives Demand for Enzymes and Kits
    • Growing Use of Molecular Biology Enzymes and Kits in Agriculture and Food Safety Testing Expands Market Potential
    • Focus on Reducing Experiment Time and Improving Workflow Efficiency Strengthens Market for Molecular Biology Reagents
    • Rising Adoption of Molecular Biology Enzymes in Cancer Research and Biomarker Discovery Expands Addressable Market
    • Technological Advancements in Point-of-Care Molecular Diagnostic Kits Propel Market Growth
    • Expansion of Molecular Biology Reagents in Environmental and Microbial Studies Expands Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Enzymes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Enzymes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Academic & Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Academic & Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Academic & Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospital & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospital & Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospital & Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pharma & Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Pharma & Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Cloning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 33: World 15-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 36: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 37: World Molecular Biology Enzymes and Kits & Reagents Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Molecular Biology Enzymes and Kits & Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Product - Kits & Reagents and Enzymes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Product - Percentage Breakdown of Value Sales for Kits & Reagents and Enzymes for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by End-Use - Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by End-Use - Percentage Breakdown of Value Sales for Hospital & Diagnostics, Other End-Uses, Academic & Research and Pharma & Biotech for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Molecular Biology Enzymes and Kits & Reagents by Application - PCR, Sequencing, Cloning, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Molecular Biology Enzymes and Kits & Reagents by Application - Percentage Breakdown of Value Sales for PCR, Sequencing, Cloning, Epigenetics and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION